US Markets

Qatar signs deal to buy Moderna COVID-19 vaccine

Credit: REUTERS/BRIAN SNYDER

Qatar has signed an agreement with drugmaker Moderna Inc to buy its potential COVID-19 vaccine as soon as it is approved and released for global use, state news agency QNA quoted a health official as saying on Sunday.

DUBAI, Oct 25 (Reuters) - Qatar has signed an agreement with drugmaker Moderna Inc MRNA.O to buy its potential COVID-19 vaccine as soon as it is approved and released for global use, state news agency QNA quoted a health official as saying on Sunday.

There are no internationally approved vaccines yet, but several are in advanced trials, including from Pfizer Inc PFE.N, Johnson & Johnson JNJ.N and Moderna.

"Negotiating early and securing a number of agreements enhances our chances of getting sufficient quantities of the vaccine early," said Abdullatif al-Khal, chair of a national COVID-19 health group and head of infectious diseases at Hamad Medical Corporation.

He did not say how many doses Doha was requesting. Earlier this month, al-Khal said Qatar signed an agreement with Pfizer and BioNTech to supply Qatar with their vaccines.

Moderna said last month it was on track to produce 20 million doses of its vaccine by the end of the year, while maintaining its goal of readying 500 million to 1 billion doses in 2021.

The American group is also working with Swiss group Lonza AG to scale up the manufacturing and production of its potential COVID-19 vaccine to supply markets outside the United States.

(Reporting by Yousef Saba; Writing by Ghaida Ghantous; Editing by Andrew Heavens)

((ghaida.ghantous@thomsonreuters.com;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA PFE JNJ

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More